Associations of Metabolic Syndrome and Diabetes Mellitus with 16-year Survival After CABG

Overview

Journal Cardiovasc Diabetol

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
Endocrinology

Date 2014 Jan 23

PMID 24447406

Citations 14

Authors

Ville Hallberg

Ari Palomaki

Jorma Lahtela

Seppo Voutilainen

Matti Tarkka

Matti Kataja

Affiliations

Soon will be listed here.

Abstract

Background: The associations of metabolic syndrome (MetS) or diabetes mellitus (DM) on long-term survival after coronary artery bypass grafting (CABG) have not been extensively evaluated. The aim of the present study was to assess the impact of MetS and DM on the 16-year survival after CABG.

Methods: Diabetic and metabolic status together with relevant cardiovascular data was established in 910 CABG patients operated in 1993-94. They were divided in three groups as follows: neither DM nor MetS (375 patients), MetS alone (279 patients) and DM with or without MetS (256 patients). The 16-year follow-up of patient survival was carried out using national health databases. The relative survival rates were analyzed using the Life Table method comparing the observed survival rates of three patient groups to the rates based on age-, sex- and time-specific life tables for the whole population in Finland. To study the independent significance of MetS and DM for clinical outcome, multivariate analysis was made using an optimizing stepwise procedure based on the Bayesian approach.

Results: Bayesian multivariate analysis revealed together six variables to predict clinical outcome (2 months to 16 years) in relation to the national background population, i.e. age, diabetes, left ventricular ejection fraction, BMI, perfusion time during the CABG and peripheral arterial disease. Our principal finding was that after postoperative period the 16-year prognosis of patients with neither DM nor MetS was better than that of the age-, sex-and time-matched background population (relative survival against background population 1.037, p < 0.0001). The overall survival of MetS patients resembled that of the matched background population (relative survival 0.998, NS). DM was associated with significantly increased mortality (relative survival 0.86, p < 0.0001). Additionally, mortality was even higher in patients receiving insulin treatment than in those without. Excess death rate of DM patients was predominantly caused by cardiovascular causes.

Conclusion: In this long-term follow-up study patient groups without diabetes had at least equal 16 years' survival after CABG than their matched background populations. Survival of DM patients started to deteriorate already few years after the operation.

Citing Articles

Effect of Type-2 Diabetes Mellitus on the Expression and Function of Smooth Muscle ATP-Sensitive Potassium Channels in Human Internal Mammary Artery Grafts.

Rajkovic J, Peric M, Stanisic J, Gostimirovic M, Novakovic R, Djokic V Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065708 PMC: 11280115. DOI: 10.3390/ph17070857.

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with coronary heart disease and type 2 diabetes mellitus: Cumulative meta-analysis.

Xie Q, Huang J, Zhu K, Chen Q Clin Cardiol. 2021; 44(7):899-906.

PMID: 34089266 PMC: 8259162. DOI: 10.1002/clc.23613.

Metabolomics window into the role of acute kidney injury after coronary artery bypass grafting in diabetic nephropathy progression.

Wang J, Yan W, Zhou X, Liu Y, Tang C, Peng Y PeerJ. 2020; 8:e9111.

PMID: 32461830 PMC: 7231503. DOI: 10.7717/peerj.9111.

The role of robotics in cardiac surgery: a systematic review.

Doulamis I, Spartalis E, Machairas N, Schizas D, Patsouras D, Spartalis M J Robot Surg. 2018; 13(1):41-52.

PMID: 30255360 DOI: 10.1007/s11701-018-0875-5.

Which factor is the most effective one in metabolic Sydrome on the outcomes after coronary artery bypass graft surgery? A cohort study of 5 Years.

Wang L, Qian X, Wang M, Tang X, Ao H J Cardiothorac Surg. 2018; 13(1):1.

PMID: 29301583 PMC: 5753490. DOI: 10.1186/s13019-017-0682-5.

References

Hakulinen T . On long-term relative survival rates. J Chronic Dis. 1977; 30(7):431-43. DOI: 10.1016/0021-9681(77)90036-4. View

Ford E . Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005; 28(7):1769-78. DOI: 10.2337/diacare.28.7.1769. View

Cavaghan M, Ehrmann D, Polonsky K . Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest. 2000; 106(3):329-33. PMC: 314336. DOI: 10.1172/JCI10761. View

Reaven G . The metabolic syndrome: time to get off the merry-go-round?. J Intern Med. 2010; 269(2):127-36. DOI: 10.1111/j.1365-2796.2010.02325.x. View

Haffner S, Lehto S, Ronnemaa T, Pyorala K, Laakso M . Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339(4):229-34. DOI: 10.1056/NEJM199807233390404. View

Ketonen M, Pajunen P, Koukkunen H, Immonen-Raiha P, Mustonen J, Mahonen M . Long-term prognosis after coronary artery bypass surgery. Int J Cardiol. 2007; 124(1):72-9. DOI: 10.1016/j.ijcard.2006.12.026. View

Alberti K, Zimmet P . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15(7):539-53. DOI: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. View

Nigam A, Bourassa M, Fortier A, Guertin M, Tardif J . The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease. Am Heart J. 2006; 151(2):514-21. DOI: 10.1016/j.ahj.2005.03.050. View

Park Y, Zhu S, Palaniappan L, Heshka S, Carnethon M, Heymsfield S . The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003; 163(4):427-36. PMC: 3146257. DOI: 10.1001/archinte.163.4.427. View

10.

Carson J, Scholz P, Chen A, Peterson E, Gold J, Schneider S . Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002; 40(3):418-23. DOI: 10.1016/s0735-1097(02)01969-1. View

11.

Lorenzo C, Williams K, Hunt K, Haffner S . The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2006; 30(1):8-13. DOI: 10.2337/dc06-1414. View

12.

Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immonen-Raiha P, Karja-Koskenkari P . The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil. 2005; 12(2):132-7. DOI: 10.1097/00149831-200504000-00007. View

13.

Hakala T, Pitkanen O, Halonen P, Mustonen J, Turpeinen A, Hippelainen M . Early and late outcome after coronary artery bypass surgery in diabetic patients. Scand Cardiovasc J. 2005; 39(3):177-81. DOI: 10.1080/14017430510009113. View

14.

Stimpson J, Wilson F, Murillo R, Pagan J . Persistent disparities in cholesterol screening among immigrants to the United States. Int J Equity Health. 2012; 11:22. PMC: 3384474. DOI: 10.1186/1475-9276-11-22. View

15.

Thourani V, Weintraub W, Stein B, Gebhart S, Craver J, Jones E . Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg. 1999; 67(4):1045-52. DOI: 10.1016/s0003-4975(99)00143-5. View

16.

Vonbank A, Saely C, Rein P, Drexel H . Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease. Cardiovasc Diabetol. 2013; 12:106. PMC: 3720189. DOI: 10.1186/1475-2840-12-106. View

17.

Pohjantahti-Maaroos H, Palomaki A, Kankkunen P, Laitinen R, Husgafvel S, Oksanen K . Circulating oxidized low-density lipoproteins and arterial elasticity: comparison between men with metabolic syndrome and physically active counterparts. Cardiovasc Diabetol. 2010; 9:41. PMC: 2931500. DOI: 10.1186/1475-2840-9-41. View

18.

Yatskar L, Holper E, Bansilal S, Schwartzbard A, Lombardero M, Ramanathan K . Long-term outcomes in non-diabetic patients with metabolic syndrome undergoing revascularization for multi-vessel coronary artery disease. Atherosclerosis. 2007; 198(2):389-95. DOI: 10.1016/j.atherosclerosis.2007.09.046. View

19.

Mazurek M, Kowalczyk J, Lenarczyk R, Zielinska T, Sedkowska A, Pruszkowska-Skrzep P . The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively. Cardiovasc Diabetol. 2012; 11:78. PMC: 3490817. DOI: 10.1186/1475-2840-11-78. View

20.

Alserius T, Hammar N, Nordqvist T, Ivert T . Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes. Am Heart J. 2006; 152(3):599-605. DOI: 10.1016/j.ahj.2006.02.010. View